UA86929C2 - Controlled-release compositions - Google Patents

Controlled-release compositions

Info

Publication number
UA86929C2
UA86929C2 UAA200504938A UA2005004938A UA86929C2 UA 86929 C2 UA86929 C2 UA 86929C2 UA A200504938 A UAA200504938 A UA A200504938A UA 2005004938 A UA2005004938 A UA 2005004938A UA 86929 C2 UA86929 C2 UA 86929C2
Authority
UA
Ukraine
Prior art keywords
controlled
release
matrix
agent
release compositions
Prior art date
Application number
UAA200504938A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Венсан Ленар
Патрисия Лаура Оуаджи-Нджики
Джонатан Бейкон
Рашид Узеруру
Соня Жерве
Милу Рахмуни
Деймон Смит
Original Assignee
Лабофарм Інк.
Лабофарм Юроп Лимитед
Лабофарм (Барбадос) Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лабофарм Інк., Лабофарм Юроп Лимитед, Лабофарм (Барбадос) Лимитед filed Critical Лабофарм Інк.
Publication of UA86929C2 publication Critical patent/UA86929C2/en

Links

Abstract

A solid dosage formulation having a core with a pharmacological agent dispersed in a first controlled-release matrix from which release of the agent is relatively slow; and a coat formed over the core and having the agent dispersed in a second controlled-release matrix from which release of the agent is relatively fast. The first matrix can be a cross-linked high amylose starch and the second matrix can be a mixture of polyvinyl acetate and polyvinylpyrrolidone.
UAA200504938A 2002-10-25 2003-10-27 Controlled-release compositions UA86929C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50906202P 2002-10-25 2002-10-25

Publications (1)

Publication Number Publication Date
UA86929C2 true UA86929C2 (en) 2009-06-10

Family

ID=38293473

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200504938A UA86929C2 (en) 2002-10-25 2003-10-27 Controlled-release compositions

Country Status (2)

Country Link
UA (1) UA86929C2 (en)
ZA (2) ZA200504215B (en)

Also Published As

Publication number Publication date
ZA200504216B (en) 2006-08-30
ZA200504215B (en) 2006-09-27

Similar Documents

Publication Publication Date Title
HK1086475A1 (en) Controlled-release compositions
RS20080181A (en) Solid pharmaceutical compositions containing pregabalin, a matrix forming agent and a swelling agent
NZ515359A (en) Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
TWI235068B (en) Sustained-release pharmaceutical composition
JO2555B1 (en) Oral dosage forms for propiverine or pharmaceutically acceptable salts thereof having prolonged release of the active agent
MX9707585A (en) Homogeneous mixtures of low temperature-melting drugs and additives for controlled release.
PL1631251T3 (en) Delayed release tablet with defined core geometry
GEP20074022B (en) Pharmaceutical formulations comprising oxycodone and naloxone
CA2457361A1 (en) Opioid agonist formulations with releasable and sequestered antagonist
CO4700474A1 (en) ORAL FORMULATION OF 2-METHYL-THENO-BENZODIACEPINE
MXPA05012637A (en) Modified-release tablet of bupropion hydrochloride.
BG105061A (en) Enteric coated pharmaceutical composition and method of manufacturing
HUP0301302A2 (en) Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and process for its manufacture
IE881195L (en) Ibuprofen sustained release matrix
WO2004064815A8 (en) Oral dosage formulation
PL2057984T3 (en) Retard tablets with hydromorphon
ATE185266T1 (en) RAPID DISSOLVING ORAL PHARMACEUTICAL FORM
MY142195A (en) Controlled-release compositions
UA86929C2 (en) Controlled-release compositions
WO2003034822A3 (en) Powdery active ingredient formulations
WO2003057278A3 (en) Drug delivery system for sustained delivery of glipizide
WO2003051370A8 (en) Selective dopamine d3 receptor agonists for the treatment of sexual dysfunction
MX2009013054A (en) Pharmaceutical composition comprising a substrate and a coating containing an active ingredient and polyvinylalcohol.
CA2399856A1 (en) Antibiotic composition with inhibitor
PT1499278E (en) IMMEDIATE RELEASE PHARMACEUTICAL FORM FOR COMPOSITION OF TIBOLONE POLYMER